Brief: NLS Pharmaceutics Ltd Files Prospectus To The Resale, From Time To Time, By The Selling Shareholders Of Up To 11.9 Mln Common Shares - SEC Filing
Dec 6 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS LTD. FILES PROSPECTUS TO THE RESALE,
FROM TIME
TO TIME, BY THE SELLING SHAREHOLDERS OF UP TO 11.9 MILLION
COMMON SHARES - SEC FILING
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing